Sept 16- Siga Technologies Inc, a supplier of antiviral smallpox drug to the U.S. strategic stockpile, filed for voluntary bankruptcy protection as it seeks time to appeal a court order favoring PharmAthene Inc in a licensing dispute.
Sept 16- Siga Technologies Inc filed for voluntary bankruptcy protection on Tuesday and said the filing was to preserve its ability to supply its antiviral smallpox drug to the U.S. Siga listed total assets of $209.5 million and liabilities of $197.9 million in its Chapter 11 petition with the Southern District of New York.
The House Oversight Committee wants to know if the National Labor Relations Board overstepped its authority and is stifling American competitiveness, Chairman Rep. Darrell Issa told CNBC Friday.
Financier Ron Perelman’s entry into the smallpox antiviral medicine business has led to a congressional investigation, CNBC has learned.
Get Cramer's calls on the stocks home gamers asked about.
The Lightning Round is extended in this CNBC.com exclusive feature.